Anika Therapeutics, Inc. Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31)
Anika Therapeutics, Inc. (ANIK) had Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) of 1.43% as of 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentInterestRateAtPeriodEnd · last filed 2013-11-05
- 2013-09-30: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 1.43%.
- 2013-06-30: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 1.48%.
- 2013-03-31: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 1.53%.
- 2012-09-30: Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) 1.64%.
| Period end | Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) |
|---|---|
| 2013-09-30 | 1.43% 10-Q · filed 2013-11-05 |
| 2013-06-30 | 1.48% 10-Q · filed 2013-08-06 |
| 2013-03-31 | 1.53% 10-Q · filed 2013-05-06 |
| 2012-09-30 | 1.64% 10-Q · filed 2012-11-08 |
| 2012-06-30 | 1.72% 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |